▶ 調査レポート

世界の部位特異的ドラッグデリバリー市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Site-Specific Drug Delivery Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の部位特異的ドラッグデリバリー市場 2021:企業別、地域別、種類・用途別 / Global Site-Specific Drug Delivery Market 2021 by Company, Regions, Type and Application, Forecast to 2026 / GIR-107A11895資料のイメージです。• レポートコード:GIR-107A11895
• 出版社/出版日:GlobalInfoResearch / 2021年7月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、93ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、部位特異的ドラッグデリバリーのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。部位特異的ドラッグデリバリーの種類別市場規模(リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他)、用途別市場規模(真菌感染症治療、がん・腫瘍治療、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・部位特異的ドラッグデリバリーの市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Johnson & Johnson、Gilead Sciences、Pacira、Sun Pharmaceutical、Luye Pharma、Sigma-Tau Group、Fudan-Zhangjiang、Teva Pharmaceutical、CSPC、Novartis、Kingond Pharm
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他
・用途別分析2016年-2026年:真菌感染症治療、がん・腫瘍治療、その他
・部位特異的ドラッグデリバリーの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・部位特異的ドラッグデリバリーのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・部位特異的ドラッグデリバリーのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・部位特異的ドラッグデリバリーの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・部位特異的ドラッグデリバリーの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Site-Specific Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Site-Specific Drug Delivery size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Site-Specific Drug Delivery market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Site-Specific Drug Delivery market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Other

Market segment by Application, can be divided into
Fungal Infection Therapy
Cancer & Tumor Therapy
Other

Market segment by players, this report covers
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Site-Specific Drug Delivery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Site-Specific Drug Delivery, with revenue, gross margin and global market share of Site-Specific Drug Delivery from 2019 to 2021.
Chapter 3, the Site-Specific Drug Delivery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Site-Specific Drug Delivery market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Site-Specific Drug Delivery research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Site-Specific Drug Delivery
1.2 Classification of Site-Specific Drug Delivery by Type
1.2.1 Overview: Global Site-Specific Drug Delivery Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Site-Specific Drug Delivery Revenue Market Share by Type in 2020
1.2.3 Liposomal Doxorubicin
1.2.4 Liposomal Amphoteracin B
1.2.5 Liposomal Paclitaxel
1.2.6 Other
1.3 Global Site-Specific Drug Delivery Market by Application
1.3.1 Overview: Global Site-Specific Drug Delivery Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Other
1.4 Global Site-Specific Drug Delivery Market Size & Forecast
1.5 Global Site-Specific Drug Delivery Market Size and Forecast by Region
1.5.1 Global Site-Specific Drug Delivery Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Site-Specific Drug Delivery Market Size by Region, (2016-2021)
1.5.3 North America Site-Specific Drug Delivery Market Size and Prospect (2016-2026)
1.5.4 Europe Site-Specific Drug Delivery Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Site-Specific Drug Delivery Market Size and Prospect (2016-2026)
1.5.6 South America Site-Specific Drug Delivery Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Site-Specific Drug Delivery Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Site-Specific Drug Delivery Market Drivers
1.6.2 Site-Specific Drug Delivery Market Restraints
1.6.3 Site-Specific Drug Delivery Trends Analysis
2 Company Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Site-Specific Drug Delivery Product and Solutions
2.1.4 Johnson & Johnson Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Johnson & Johnson Recent Developments and Future Plans
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business
2.2.3 Gilead Sciences Site-Specific Drug Delivery Product and Solutions
2.2.4 Gilead Sciences Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Gilead Sciences Recent Developments and Future Plans
2.3 Pacira
2.3.1 Pacira Details
2.3.2 Pacira Major Business
2.3.3 Pacira Site-Specific Drug Delivery Product and Solutions
2.3.4 Pacira Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Pacira Recent Developments and Future Plans
2.4 Sun Pharmaceutical
2.4.1 Sun Pharmaceutical Details
2.4.2 Sun Pharmaceutical Major Business
2.4.3 Sun Pharmaceutical Site-Specific Drug Delivery Product and Solutions
2.4.4 Sun Pharmaceutical Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Sun Pharmaceutical Recent Developments and Future Plans
2.5 Luye Pharma
2.5.1 Luye Pharma Details
2.5.2 Luye Pharma Major Business
2.5.3 Luye Pharma Site-Specific Drug Delivery Product and Solutions
2.5.4 Luye Pharma Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Luye Pharma Recent Developments and Future Plans
2.6 Sigma-Tau Group
2.6.1 Sigma-Tau Group Details
2.6.2 Sigma-Tau Group Major Business
2.6.3 Sigma-Tau Group Site-Specific Drug Delivery Product and Solutions
2.6.4 Sigma-Tau Group Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Sigma-Tau Group Recent Developments and Future Plans
2.7 Fudan-Zhangjiang
2.7.1 Fudan-Zhangjiang Details
2.7.2 Fudan-Zhangjiang Major Business
2.7.3 Fudan-Zhangjiang Site-Specific Drug Delivery Product and Solutions
2.7.4 Fudan-Zhangjiang Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Fudan-Zhangjiang Recent Developments and Future Plans
2.8 Teva Pharmaceutical
2.8.1 Teva Pharmaceutical Details
2.8.2 Teva Pharmaceutical Major Business
2.8.3 Teva Pharmaceutical Site-Specific Drug Delivery Product and Solutions
2.8.4 Teva Pharmaceutical Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Teva Pharmaceutical Recent Developments and Future Plans
2.9 CSPC
2.9.1 CSPC Details
2.9.2 CSPC Major Business
2.9.3 CSPC Site-Specific Drug Delivery Product and Solutions
2.9.4 CSPC Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 CSPC Recent Developments and Future Plans
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Site-Specific Drug Delivery Product and Solutions
2.10.4 Novartis Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Novartis Recent Developments and Future Plans
2.11 Kingond Pharm
2.11.1 Kingond Pharm Details
2.11.2 Kingond Pharm Major Business
2.11.3 Kingond Pharm Site-Specific Drug Delivery Product and Solutions
2.11.4 Kingond Pharm Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Kingond Pharm Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Site-Specific Drug Delivery Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Site-Specific Drug Delivery Players Market Share
3.2.2 Top 10 Site-Specific Drug Delivery Players Market Share
3.2.3 Market Competition Trend
3.3 Site-Specific Drug Delivery Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Site-Specific Drug Delivery Revenue and Market Share by Type (2016-2021)
4.2 Global Site-Specific Drug Delivery Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Site-Specific Drug Delivery Revenue Market Share by Application (2016-2021)
5.2 Site-Specific Drug Delivery Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Site-Specific Drug Delivery Revenue by Type (2016-2026)
6.2 North America Site-Specific Drug Delivery Revenue by Application (2016-2026)
6.3 North America Site-Specific Drug Delivery Market Size by Country
6.3.1 North America Site-Specific Drug Delivery Revenue by Country (2016-2026)
6.3.2 United States Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
6.3.3 Canada Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
6.3.4 Mexico Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Site-Specific Drug Delivery Revenue by Type (2016-2026)
7.2 Europe Site-Specific Drug Delivery Revenue by Application (2016-2026)
7.3 Europe Site-Specific Drug Delivery Market Size by Country
7.3.1 Europe Site-Specific Drug Delivery Revenue by Country (2016-2026)
7.3.2 Germany Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
7.3.3 France Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
7.3.5 Russia Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
7.3.6 Italy Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Site-Specific Drug Delivery Revenue by Type (2016-2026)
8.2 Asia-Pacific Site-Specific Drug Delivery Revenue by Application (2016-2026)
8.3 Asia-Pacific Site-Specific Drug Delivery Market Size by Region
8.3.1 Asia-Pacific Site-Specific Drug Delivery Revenue by Region (2016-2026)
8.3.2 China Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
8.3.3 Japan Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
8.3.4 South Korea Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
8.3.5 India Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
8.3.7 Australia Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Site-Specific Drug Delivery Revenue by Type (2016-2026)
9.2 South America Site-Specific Drug Delivery Revenue by Application (2016-2026)
9.3 South America Site-Specific Drug Delivery Market Size by Country
9.3.1 South America Site-Specific Drug Delivery Revenue by Country (2016-2026)
9.3.2 Brazil Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
9.3.3 Argentina Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Site-Specific Drug Delivery Revenue by Type (2016-2026)
10.2 Middle East & Africa Site-Specific Drug Delivery Revenue by Application (2016-2026)
10.3 Middle East & Africa Site-Specific Drug Delivery Market Size by Country
10.3.1 Middle East & Africa Site-Specific Drug Delivery Revenue by Country (2016-2026)
10.3.2 Turkey Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
10.3.4 UAE Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Site-Specific Drug Delivery Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Site-Specific Drug Delivery Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Site-Specific Drug Delivery Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Site-Specific Drug Delivery Revenue (USD Million) by Region (2016-2021)
Table 5. Global Site-Specific Drug Delivery Revenue Market Share by Region (2021-2026)
Table 6. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 7. Johnson & Johnson Major Business
Table 8. Johnson & Johnson Site-Specific Drug Delivery Product and Solutions
Table 9. Johnson & Johnson Site-Specific Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Gilead Sciences Corporate Information, Head Office, and Major Competitors
Table 11. Gilead Sciences Major Business
Table 12. Gilead Sciences Site-Specific Drug Delivery Product and Solutions
Table 13. Gilead Sciences Site-Specific Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Pacira Corporate Information, Head Office, and Major Competitors
Table 15. Pacira Major Business
Table 16. Pacira Site-Specific Drug Delivery Product and Solutions
Table 17. Pacira Site-Specific Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Sun Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 19. Sun Pharmaceutical Major Business
Table 20. Sun Pharmaceutical Site-Specific Drug Delivery Product and Solutions
Table 21. Sun Pharmaceutical Site-Specific Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Luye Pharma Corporate Information, Head Office, and Major Competitors
Table 23. Luye Pharma Major Business
Table 24. Luye Pharma Site-Specific Drug Delivery Product and Solutions
Table 25. Luye Pharma Site-Specific Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Sigma-Tau Group Corporate Information, Head Office, and Major Competitors
Table 27. Sigma-Tau Group Major Business
Table 28. Sigma-Tau Group Site-Specific Drug Delivery Product and Solutions
Table 29. Sigma-Tau Group Site-Specific Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Fudan-Zhangjiang Corporate Information, Head Office, and Major Competitors
Table 31. Fudan-Zhangjiang Major Business
Table 32. Fudan-Zhangjiang Site-Specific Drug Delivery Product and Solutions
Table 33. Fudan-Zhangjiang Site-Specific Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Teva Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 35. Teva Pharmaceutical Major Business
Table 36. Teva Pharmaceutical Site-Specific Drug Delivery Product and Solutions
Table 37. Teva Pharmaceutical Site-Specific Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. CSPC Corporate Information, Head Office, and Major Competitors
Table 39. CSPC Major Business
Table 40. CSPC Site-Specific Drug Delivery Product and Solutions
Table 41. CSPC Site-Specific Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Novartis Corporate Information, Head Office, and Major Competitors
Table 43. Novartis Major Business
Table 44. Novartis Site-Specific Drug Delivery Product and Solutions
Table 45. Novartis Site-Specific Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Kingond Pharm Corporate Information, Head Office, and Major Competitors
Table 47. Kingond Pharm Major Business
Table 48. Kingond Pharm Site-Specific Drug Delivery Product and Solutions
Table 49. Kingond Pharm Site-Specific Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global Site-Specific Drug Delivery Revenue (USD Million) by Players (2019-2021)
Table 51. Global Site-Specific Drug Delivery Revenue Share by Players (2019-2021)
Table 52. Breakdown of Site-Specific Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Site-Specific Drug Delivery Players Head Office, Products and Services Provided
Table 54. Site-Specific Drug Delivery Mergers & Acquisitions in the Past Five Years
Table 55. Site-Specific Drug Delivery New Entrants and Expansion Plans
Table 56. Global Site-Specific Drug Delivery Revenue (USD Million) by Type (2016-2021)
Table 57. Global Site-Specific Drug Delivery Revenue Share by Type (2016-2021)
Table 58. Global Site-Specific Drug Delivery Revenue Forecast by Type (2021-2026)
Table 59. Global Site-Specific Drug Delivery Revenue by Application (2016-2021)
Table 60. Global Site-Specific Drug Delivery Revenue Forecast by Application (2021-2026)
Table 61. North America Site-Specific Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 62. North America Site-Specific Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 63. North America Site-Specific Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 64. North America Site-Specific Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 65. North America Site-Specific Drug Delivery Revenue by Country (2016-2021) & (USD Million)
Table 66. North America Site-Specific Drug Delivery Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe Site-Specific Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe Site-Specific Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe Site-Specific Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe Site-Specific Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe Site-Specific Drug Delivery Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe Site-Specific Drug Delivery Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific Site-Specific Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific Site-Specific Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific Site-Specific Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific Site-Specific Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific Site-Specific Drug Delivery Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific Site-Specific Drug Delivery Revenue by Region (2021-2026) & (USD Million)
Table 79. South America Site-Specific Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 80. South America Site-Specific Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 81. South America Site-Specific Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 82. South America Site-Specific Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 83. South America Site-Specific Drug Delivery Revenue by Country (2016-2021) & (USD Million)
Table 84. South America Site-Specific Drug Delivery Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa Site-Specific Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa Site-Specific Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa Site-Specific Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa Site-Specific Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa Site-Specific Drug Delivery Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa Site-Specific Drug Delivery Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Site-Specific Drug Delivery Picture
Figure 2. Global Site-Specific Drug Delivery Revenue Market Share by Type in 2020
Figure 3. Liposomal Doxorubicin
Figure 4. Liposomal Amphoteracin B
Figure 5. Liposomal Paclitaxel
Figure 6. Other
Figure 7. Site-Specific Drug Delivery Revenue Market Share by Application in 2020
Figure 8. Fungal Infection Therapy Picture
Figure 9. Cancer & Tumor Therapy Picture
Figure 10. Other Picture
Figure 11. Global Site-Specific Drug Delivery Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Site-Specific Drug Delivery Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Site-Specific Drug Delivery Revenue Market Share by Region (2016-2026)
Figure 14. Global Site-Specific Drug Delivery Revenue Market Share by Region in 2020
Figure 15. North America Site-Specific Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Site-Specific Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Site-Specific Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Site-Specific Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Site-Specific Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Site-Specific Drug Delivery Market Drivers
Figure 21. Site-Specific Drug Delivery Market Restraints
Figure 22. Site-Specific Drug Delivery Market Trends
Figure 23. Johnson & Johnson Recent Developments and Future Plans
Figure 24. Gilead Sciences Recent Developments and Future Plans
Figure 25. Pacira Recent Developments and Future Plans
Figure 26. Sun Pharmaceutical Recent Developments and Future Plans
Figure 27. Luye Pharma Recent Developments and Future Plans
Figure 28. Sigma-Tau Group Recent Developments and Future Plans
Figure 29. Fudan-Zhangjiang Recent Developments and Future Plans
Figure 30. Teva Pharmaceutical Recent Developments and Future Plans
Figure 31. CSPC Recent Developments and Future Plans
Figure 32. Novartis Recent Developments and Future Plans
Figure 33. Kingond Pharm Recent Developments and Future Plans
Figure 34. Global Site-Specific Drug Delivery Revenue Share by Players in 2020
Figure 35. Site-Specific Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Site-Specific Drug Delivery Revenue Market Share in 2020
Figure 37. Global Top 10 Players Site-Specific Drug Delivery Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Site-Specific Drug Delivery Revenue Share by Type in 2020
Figure 40. Global Site-Specific Drug Delivery Market Share Forecast by Type (2021-2026)
Figure 41. Global Site-Specific Drug Delivery Revenue Share by Application in 2020
Figure 42. Global Site-Specific Drug Delivery Market Share Forecast by Application (2021-2026)
Figure 43. North America Site-Specific Drug Delivery Sales Market Share by Type (2016-2026)
Figure 44. North America Site-Specific Drug Delivery Sales Market Share by Application (2016-2026)
Figure 45. North America Site-Specific Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 46. United States Site-Specific Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Site-Specific Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Site-Specific Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Site-Specific Drug Delivery Sales Market Share by Type (2016-2026)
Figure 50. Europe Site-Specific Drug Delivery Sales Market Share by Application (2016-2026)
Figure 51. Europe Site-Specific Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 52. Germany Site-Specific Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Site-Specific Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Site-Specific Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Site-Specific Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Site-Specific Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Site-Specific Drug Delivery Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Site-Specific Drug Delivery Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Site-Specific Drug Delivery Revenue Market Share by Region (2016-2026)
Figure 60. China Site-Specific Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Site-Specific Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Site-Specific Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Site-Specific Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Site-Specific Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Site-Specific Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Site-Specific Drug Delivery Sales Market Share by Type (2016-2026)
Figure 67. South America Site-Specific Drug Delivery Sales Market Share by Application (2016-2026)
Figure 68. South America Site-Specific Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Site-Specific Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Site-Specific Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Site-Specific Drug Delivery Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Site-Specific Drug Delivery Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Site-Specific Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Site-Specific Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Site-Specific Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Site-Specific Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source